Unsuccessful developing lung cancer drugs in the U.S. 1998-2014
Number of unsuccessful lung cancer drugs in the United States from 1998 to 2014
This statistic depicts the number of unsuccessful lung cancer drugs that were developed in the United States from 1998 to 2014. In 2011, there were 13 unsuccessfully developed lung cancer drugs. Since 1998, there have been 167 total medicines being developed for lung cancer that were discontinued, suspended, or had no development reported and 10 approved medications.
Number of unsuccessful lung cancer drugs in the United States from 1998 to 2014
Loading statistic...
| Number of drugs no longer under development | |
|---|---|
| 2014 | 6 |
| 2013 | 23 |
| 2012 | 11 |
| 2011 | 13 |
| 2010 | 14 |
| 2009 | 11 |
| 2008 | 15 |
| 2007 | 25 |
| 2006 | 6 |
| 2005 | 7 |
| 2004 | 11 |
| 2003 | 4 |
| 2002 | 8 |
| 2001 | 4 |
| 2000 | 3 |
| 1999 | 4 |
| 1998 | 2 |
Source
More information
Statistics on "Oncology"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Unsuccessful developing melanoma drugs in the U.S. 1998-2014
- Unsuccessful developing brain cancer drugs in the U.S. 1998-2014
- Average prices of Gleevec - selected countries 2013
- Revenue since approval for select cancer drugs 2017
- Revenue as a part of R&D spending for select cancer drugs 2017
- Italy: consumption of cancer drugs 2017, by region
- Net price index for cancer products in developed markets 2014
- Metastatic cancer treatment market worldwide 2017 and 2025
- U.S. average invoice price increase for oncology brands 2012-2017
- Number of new cancer pharmaceuticals approved by EMA in Sweden 2014-2017
- Top cancer drugs paid by Medicare Part B by sales price per dosage 2014
- Italy: number of clinical trials 2017, by type of drug
- Anti-cancer drugs estimated market size in South Korea 2014-2020
- Italy: public expenditure on the most prescribed drugs 2017, by category
- Italy: public expenditure on innovative drugs 2015-2017
- Italy: number of clinical trials for rare diseases 2017, by funding institution
- Cancer drugs on the world market 2010
- Global nanopharmaceutical drug total market 2018 and 2026
- Bristol-Myers Squibb's revenue by region 2010-2018
- Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2018
Statistics on "Oncology"
Related topics
About Statista
